Evidence map›Paper›PMID 40335547›Full record

ArticleNature communications2025

Immunomodulatory multifunctional janus collagen-based membrane for advanced bone regeneration.

Die Yang, Zhilang Xu, Dou Huang, Qi Luo, Chunli Zhang, Jimin Guo, Lu Tan, Liming Ge, Changdao Mu, Defu Li

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Die Yang *Department of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China.ORCID http://orcid.org/0009-0001-4270-5688
Zhilang Xu *Department of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China.ORCID http://orcid.org/0000-0002-0286-342X
Dou HuangDepartment of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, P. R. China.
Qi LuoDepartment of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China.
Chunli ZhangDepartment of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China.
Jimin GuoState Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing, P. R. China. guoj@buct.edu.cn.ORCID http://orcid.org/0000-0002-8249-1880
Lu TanDepartment of Osteology, Wushan County Hospital of Traditional Chinese Medicine, Wushan, Chongqing, P. R. China.
Liming GeDepartment of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China. geliming@scu.edu.cn.ORCID http://orcid.org/0009-0003-6675-5334
Changdao MuDepartment of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China.
Defu LiDepartment of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan, P. R. China. lidefu@scu.edu.cn.ORCID http://orcid.org/0000-0001-6466-4947

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22305164Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) L244036
6 · The paper itself

Abstract

Guided bone regeneration (GBR) is a standard therapy for treating bone defects, with collagen-based barrier membranes widely used clinically. However, these membranes face challenges like poor mechanical properties, early bacterial invasion and immunomodulation deficiency, potentially risking GBR failure. Orchestrating macrophage activation and controlling their M1 or M2 polarization are effective strategies for bone repair. Here, we present a Janus collagen-based barrier membrane with immunomodulation. The porous layer promotes direct osteogenic differentiation and inward growth of osteoblasts. The dense layer prevents invasion of soft tissue into bone defects and protects bone defects from bacterial infection. The membrane also enhances rat bone marrow-derived mesenchymal stem cell infiltration, proliferation, and osteogenic differentiation by regulating the immune microenvironment, demonstrating superior bone regeneration compared to the commercial Bio-Gide® membrane. Overall, the Janus collagen-based membrane reduces tissue inflammation and fosters an osteoimmune environment conducive to new bone formation, offering effective material design for advanced GBR technology.

Indexed as

Bone RegenerationCollagenMembranes, ArtificialAnimalsCell DifferentiationCell ProliferationGuided Tissue RegenerationImmunomodulationMaleMesenchymal Stem CellsMiceOsteoblastsOsteogenesisRatsRats, Sprague-DawleyCollagenMembranes, Artificial

Identifiers

PMID40335547
PMCPMC12059164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.